Statistically, neither participants with high insulin levels (PR: 1.18; CI: 0.75-1.85; P = 0.46; Table 3) nor past COVID-19 status (PR: 0.98; CI: 0.92-1.04; P = 0.56; Table 3) demonstrated increased prevalence of insulin resistance compared to their counterparts with normal levels of the parameter or without past COVID-19 status in our context. Here, INS is linked to COVID-19.